CytomX Therapeutics CTMX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$18.25M-178% | -$26.51M-240% | -$14.23M-348% | -$154K+97.6% | $23.53M+70.6% | ||
| $4.71M+134% | $1.48M-21.5% | $1.38M-30.6% | $1.43M-24.0% | $2.01M+5.3% | ||
| -$25.55M-21.4% | -$23.24M-16.8% | -$15.55M+25.0% | -$15.75M+19.4% | -$21.04M+19.2% | ||
| $0-100% | $201K+151% | —— | $27K-71.9% | $119K+3.5% | ||
| -$192.78M-730% | -$14.42M-195% | $0-100% | -$76.36M-455% | $30.6M-31.8% | ||
| $234.49M— | $16.64M+640% | $253K— | $93.55M+1,735% | $0-100% | ||
| $16.16M+69.2% | -$21.02M— | -$14.86M— | $1.44M-79.7% | $9.55M-49.8% | ||
| -$25.55M-20.7% | -$23.44M-17.3% | -$15.42M+25.7% | -$15.78M+19.7% | -$21.16M+19.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CytomX Therapeutics generate?
- CytomX Therapeutics (CTMX) generated -$80.1M in operating cash flow over the trailing twelve months.
- What is CytomX Therapeutics's free cash flow?
- After $347.0K of capital expenditures, CytomX Therapeutics's free cash flow was -$80.2M over the trailing twelve months, up 1.7% year over year.
- Where does CytomX Therapeutics's cash flow data come from?
- Every line is extracted from CytomX Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
